Comparison of anti-spike IgG, anti-spike IgA levels and neutralizing antibody activity induced by CoronaVac and BNT162b2 vaccines in patients with inflammatory rheumatic diseases receiving immunosuppressive therapy.
Fulya CosanOzlem Unay DemirelDemet YalcinMuhammed Mert SonkayaIsilsu Ezgi UluisikOlida CecenYavuz FuruncuogluDeniz Maktav CelikmenOsman KaraErkan CeylanTimucin AvşarPublished in: BMC rheumatology (2023)
Although immunogenicity was lower in IS patients, an acceptable response was obtained with both vaccines, and significantly higher anti-Spike IgG, anti-Spike IgA, and NAb activity levels were obtained with BNT162b2.